Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Current Problems in Cardiology|May 16, 2024
Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trialsMarta Casula, Gavino Casu, Giuseppe Talanas, et al.
Journal of the American College of Cardiology|January 18, 2023
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 InfectionEliano P Navarese, Przemysław Podhajski, Paul A Gurbel, et al.
International Journal of Cardiology|July 27, 2018
Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysisEliano P Navarese, Bernhard Wernly, Michael Lichtenauer, et al.
Kardiologia Polska|July 29, 2025
One-Year Clinical Outcomes in Patients with Acute Coronary Syndrome Treated with Clopidogrel versus Prasugrel versus Ticagrelor: Results of the Polish Registry of Acute Coronary Syndromes (PL-ACS)Julia M Umińska, Michał Skrzypek, Małgorzata Ostrowska, et al.
Cardiology Journal|January 8, 2025
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpointJacek Kubica, Piotr Adamski, Robert Gajda, et al.
JACC. Cardiovascular Interventions|June 17, 2019
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary InterventionDirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, et al.
Cardiology Journal|March 20, 2025
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpointJacek Kubica, Piotr Adamski, Jolita Badariene, et al.
International Journal of Cardiology|December 8, 2024
Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpointJacek Kubica, Piotr Adamski, Małgorzata Ostrowska, et al.
Pageof 4